Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
LOADING
|||
Debt to Equity Over Time
Trending lower, above historical average, strong compound growth.
Left:
||||
Debt-to-equity ratio
Latest
1.57
↑ 97% above average
Average (9y)
0.80
Historical baseline
Range
High:4.59
Low:0.00
CAGR
+56.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | 1.57 | -65.7% |
| 2024 | 4.59 | +225.0% |
| 2023 | 1.41 | +590.4% |
| 2022 | 0.20 | +227.6% |
| 2021 | 0.06 | +36.5% |
| 2020 | 0.05 | - |
| 2019 | 0.00 | -100.0% |
| 2018 | 0.02 | -22.0% |
| 2017 | 0.03 | +9.0% |
| 2016 | 0.03 | - |